Italfarmaco secures FDA approval for Duchenne muscular dystrophy drug
The FDA has approved Duvyzat for Duchenne muscular dystrophy patients aged six years and above.
The FDA has approved Duvyzat for Duchenne muscular dystrophy patients aged six years and above.
What's Your Reaction?
